HOME >> MEDICINE >> NEWS
Penn State research shows withdrawal drug offers relief for Crohn's sufferers

A Penn State College of Medicine pilot study suggests that a drug used to ease symptoms of alcohol and drug addiction may also bring relief to people with Crohn's disease, a chronic inflammatory disorder of the intestine that affects an estimated 500,000 Americans.

In the study, patients with diagnosed Crohn's disease were treated with a low dose of naltrexone, an FDA-approved drug used to ease symptoms of withdrawal from substance abuse, and monitored for improvement of symptoms for 12 weeks. Quality of life surveys were given every four weeks for 16 weeks.

Jill P. Smith, a gastroenterology specialist and researcher at the College of Medicine and Penn State Milton S. Hershey Medical Center, presented her findings recently in Los Angeles at the National Association of Gastroenterologists annual Digestive Diseases Week conference.

The results showed that 89 percent of participants showed an improvement with therapy, while 67 percent achieved remission of symptoms. The only side effect to treatment was sleep disturbance in some patients.

Typical treatment for Crohn's involves using steroids or corticosteroids, which suppress the immune system and can have other toxic side effects. Treatment is often time-intensive and expensive, as well.

"This is a novel approach to treating a common disease, and it's simple, it's safe, and it costs far less than current standards of treatment," Smith said. "We don't yet know the exact mechanisms involved in how it works, but we're working on that as well."

Smith initiated the study using a Dean's Feasibility Grant -- a program designed to encourage investigators to design trials in their area of expertise and seek outside funding. The National Institutes of Health (NIH) recently awarded the College of Medicine $500,000 for the team to continue the study.

In a related study, Smith and other College of Medicine researchers are studying the chemical and molecular mechanisms involv
'"/>

Contact: Megan W. Manlove
mwm18@psu.edu
717-531-8604
Penn State
26-May-2006


Page: 1 2

Related medicine news :

1. States taking action to insure nations 13.3M uninsured young adults
2. K-State researcher working on a way to make snack foods with extra fiber
3. State spending keeps childless seniors out of nursing homes
4. Mammography rates declining in the United States
5. States spending may help keep childless seniors independent
6. Conference honoring UH professor attracts researchers from United States, abroad
7. K-State National Agricultural Biosecurity Center director speaker at AAAS Biosecurity Symposium
8. Investment level in HIV prevention programs related to HIV incidence in the United States
9. States with higher levels of gun ownership have higher homicide rates
10. Nursing home or hospital: State policy has big impact on elderly
11. NC State start-up looks to turn lights out on flu, other viruses

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/22/2020)... ... July 22, 2020 , ... ... of its new Data Curation as a Service (DCaaS) solution for payers, providers, ... on specific clinical data curation parameters and are custom tailored to provide clients ...
(Date:7/18/2020)... MIAMI (PRWEB) , ... July 17, 2020 , ... “Frozen.” ... happen to a shoulder joint – oftentimes for unknown reasons – resulting in stiffness, ... Badia MD , an expert in treating problems of the upper limbs and joints ...
(Date:7/18/2020)... ... July 17, 2020 , ... Believing that everyone ... is evolving its brand. While the global company continues to offer weight wellness ... emotional, and spiritual wellbeing. The company announced the news today at its virtual ...
(Date:7/10/2020)... ... July 10, 2020 , ... Circularity ... line with Circularity Healthcare’s mission to provide real and affordable healthcare solutions ... help prevent future pandemics by ending the commercial trade in wild animals, expanding ...
(Date:7/10/2020)... ... July 10, 2020 , ... ... with spinal cord disease or injury and social distancing makes it even more ... symptoms of anxiety, depression, distress, and PTSD amongst our adult population and children ...
Breaking Medicine News(10 mins):
(Date:7/10/2020)... ... 2020 , ... Precision ADM, Inc. (“Precision ADM” or “the ... that their CANSWAB™ nasopharyngeal swabs are the first Canadian-made COVID-19 testing product to ... design and has trademarked the name CANSWAB™ for distribution. The collection capability has ...
(Date:7/10/2020)... FRANCISCO, Calif. (PRWEB) , ... ... ... Pharmaceutical Review , the leading review of business and technology for the ... cover the development and manufacturing of the highest quality pharmaceutical products. ...
(Date:7/7/2020)... DIEGO (PRWEB) , ... July 07, 2020 , ... SupplyPro ... The global spread of COVID-19 is affecting every one of us. SupplyPro is dedicated ... allow customers to run a Contact Tracing Report - a powerful tool in the ...
Breaking Medicine Technology:
Cached News: